Revisiting the Three Biggest Gene Editing Stocks
The adage “rules are meant to be broken” doesn’t work well if you’re a disciplined investor. What’s the point of having an objective methodology if you don’t follow it? Breaking our own tech investing methodology is very uncomfortable, yet something we need to do when investing in gene editing and AI drug discovery. Both these […]